D.E. Shaw & Co
CLB icon

D.E. Shaw & Co’s Core Laboratories CLB Stock Holding History

D.E. Shaw & Co’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.99M Sell
118,426
-49,458
-29% -$885K ﹤0.01% 2920
2025
Q4 		$2.69M Sell
167,884
-11,496
-6% -$171K ﹤0.01% 2808
2025
Q3 		$2.22M Buy
179,380
+148,642
+484% +$1.74M ﹤0.01% 2896
2025
Q2 		$354K Sell
30,738
-17,614
-36% -$209K ﹤0.01% 3794
2025
Q1 		$725K Sell
48,352
-14,730
-23% -$247K ﹤0.01% 3281
2024
Q4 		$1.09M Sell
63,082
-76,098
-55% -$1.47M ﹤0.01% 3155
2024
Q3 		$2.58M Sell
139,180
-73,766
-35% -$1.48M ﹤0.01% 2504
2024
Q2 		$4.32M Sell
212,946
-31,260
-13% -$553K ﹤0.01% 1966
2024
Q1 		$4.17M Buy
244,206
+16,764
+7% +$264K ﹤0.01% 2024
2023
Q4 		$4.02M Buy
227,442
+26,115
+13% +$526K ﹤0.01% 2088
2023
Q3 		$4.83M Buy
201,327
+98,413
+96% +$2.42M 0.01% 1834
2023
Q2 		$2.39M Buy
+102,914
New +$2.33M ﹤0.01% 2484
2023
Q1 		– Sell
-13,839
Closed -$281K – 4495
2022
Q4 		$281K Buy
+13,839
New +$268K ﹤0.01% 4115
2022
Q2 		– Sell
-33,734
Closed -$1.07M – 5383
2022
Q1 		$1.07M Sell
33,734
-25,433
-43% -$713K ﹤0.01% 3861
2021
Q4 		$1.32M Buy
59,167
+49,891
+538% +$1.3M ﹤0.01% 3714
2021
Q3 		$257K Sell
9,276
-6,941
-43% -$211K ﹤0.01% 4444
2021
Q2 		$632K Sell
16,217
-76,630
-83% -$2.75M ﹤0.01% 3904
2021
Q1 		$2.67M Buy
92,847
+42,751
+85% +$1.46M ﹤0.01% 2338
2020
Q4 		$1.33M Buy
50,096
+29,080
+138% +$594K ﹤0.01% 2837
2020
Q3 		$321K Sell
21,016
-27,071
-56% -$568K ﹤0.01% 3415
2020
Q2 		$977K Sell
48,087
-320,080
-87% -$5.74M ﹤0.01% 2955
2020
Q1 		$3.81M Buy
368,167
+333,080
+949% +$9.32M 0.01% 1667
2019
Q4 		$1.32M Buy
35,087
+23,537
+204% +$1.06M ﹤0.01% 2786
2019
Q3 		$538K Sell
11,550
-11,792
-51% -$548K ﹤0.01% 3192
2019
Q2 		$1.22M Buy
23,342
+10,718
+85% +$629K ﹤0.01% 2556
2019
Q1 		$870K Sell
12,624
-39,465
-76% -$2.65M ﹤0.01% 2682
2018
Q4 		$3.11M Buy
52,089
+40,886
+365% +$3.53M ﹤0.01% 1827
2018
Q3 		$1.3M Buy
+11,203
New +$1.26M ﹤0.01% 2507
2017
Q3 		– Sell
-15,864
Closed -$1.61M – 3452
2017
Q2 		$1.61M Hold
15,864
– – ﹤0.01% 2115
2017
Q1 		$1.83M Sell
15,864
-1,800
-10% -$209K ﹤0.01% 1906
2016
Q4 		$2.12M Sell
17,664
-5,536
-24% -$613K ﹤0.01% 1952
2016
Q3 		$2.61M Buy
23,200
+16,375
+240% +$1.89M ﹤0.01% 1720
2016
Q2 		$846K Buy
+6,825
New +$824K ﹤0.01% 2513
2015
Q4 		– Sell
-9,438
Closed -$942K – 3804
2015
Q3 		$942K Buy
9,438
+7,211
+324% +$784K ﹤0.01% 2639
2015
Q2 		$254K Sell
2,227
-5,479
-71% -$664K ﹤0.01% 3484
2015
Q1 		$805K Sell
7,706
-6,984
-48% -$744K ﹤0.01% 2733
2014
Q4 		$1.77M Buy
14,690
+10,390
+242% +$1.36M ﹤0.01% 2370
2014
Q3 		$629K Sell
4,300
-72,557
-94% -$11.2M ﹤0.01% 3166
2014
Q2 		$12.8M Buy
76,857
+35,289
+85% +$6.28M 0.02% 943
2014
Q1 		$8.25M Sell
41,568
-21,735
-34% -$4.1M 0.01% 1178
2013
Q4 		$12.1M Buy
63,303
+61,380
+3,192% +$11.4M 0.02% 1003
2013
Q3 		$325K Sell
1,923
-71,046
-97% -$11M ﹤0.01% 3862
2013
Q2 		$11.1M Buy
+72,969
New +$10.3M 0.02% 813

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co's CLB Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Core Laboratories (CLB) stake by 29% in Q1 2026, selling an estimated $885K and leaving 118,426 shares worth $1.99M. The position accounts for ﹤0.01% of the portfolio, ranked #2920.

D.E. Shaw & Co first reported a position in CLB in Q2 2013 and has held it in 43 quarters since. The position peaked at $12.8M in Q2 2014. 190 funds tracked by Wall St. Rank hold CLB as of Q1 2026.

  • D.E. Shaw & Co held 118,426 shares of Core Laboratories worth $1.99M as of Q1 2026.
  • D.E. Shaw & Co sold 49,458 Core Laboratories shares in Q1 2026, an estimated $885K.
  • Core Laboratories made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2920 holding.
  • D.E. Shaw & Co first reported a position in Core Laboratories in Q2 2013 and has held it in 43 quarters since.
  • D.E. Shaw & Co's Core Laboratories position peaked at $12.8M in Q2 2014.
  • 190 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.